American Board of Urology
MD, Cornell University Medical College
Fellowship, Pediatric Urology
Childrens Hospital of Philadelphia
Castle Connolly - New York Magazine
Compassionate Doctor's Award
Patient's Choice Award
Castillo-Martin M, Collazo Lorduy A, Gladoun N, Hyun G, Cordon-Cardo C. H-RAS mutation is a key molecular feature of pediatric urothelial bladder cancer. A detailed report of three cases. Journal of pediatric urology 2016 Apr; 12(2).
Coutinho K, Stensland K, Hyun G. Circumcision on the web: a comparison of quality, content, and bias online. Journal of pediatric urology 2014 Aug; 10(4).
Fisch H, Hyun G. Varicocele repair for low testosterone. Current opinion in urology 2012 Nov; 22(6).
Van Batavia JP, Combs AJ, Hyun G, Bayer A, Medina-Kreppein D, Schlussel RN, Glassberg KI. Simplifying the diagnosis of 4 common voiding conditions using uroflow/electromyography, electromyography lag time and voiding history. The Journal of urology 2011 Oct; 186(4 Suppl).
Fisch H, Hyun G, Hensle TW. Rising hypospadias rates: disproving a myth. Journal of pediatric urology 2010 Feb; 6(1).
Fisch H, Lambert SM, Hensle TW, Hyun G. Hypospadias rates in new york state are not increasing. The Journal of urology 2009 May; 181(5).
Hensle TW, Hyun G, Grogg AL, Eaddy M. Part 2: Examining pediatric vesicoureteral reflux: a real-world evaluation of treatment patterns and outcomes. Current medical research and opinion 2007 Sep; 23 Suppl 4.
Schwab CW, Hyun G, Garibay-Gonzalez F, Canning DA, Grady RW, Casale P. Transperitoneal laparoscopic pyeloplasty for pelvic kidneys with ureteropelvic junction obstruction in children: technique and preliminary outcomes. JSLS : Journal of the Society of Laparoendoscopic Surgeons / Society of Laparoendoscopic Surgeons; 10(3).
Gonzalez F, Canning DA, Hyun G, Casale P. Lower pole pelvi-ureteric junction obstruction in duplicated collecting systems. BJU international 2006 Jan; 97(1).
Hyun G, Lowe FC. AIDS and the urologist. The Urologic clinics of North America 2003 Feb; 30(1).
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr.Hyun did not report having any of the following types of financial relationships with industry during 2016 and/or 2017: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.